Lars Fugger
Affiliations: | University of Oxford, Oxford, United Kingdom |
Area:
Multiple SclerosisGoogle:
"Lars Fugger"Mean distance: 106866 (cluster 57)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Wurm H, Attfield K, Iversen AK, et al. (2020) Recovery from COVID-19 in a B-cell-depleted multiple sclerosis patient. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520943791 |
| Huang J, Khademi M, Fugger L, et al. (2020) Inflammation-related plasma and CSF biomarkers for multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America |
| Faergeman SL, Evans H, Attfield KE, et al. (2020) A novel neurodegenerative spectrum disorder in patients with MLKL deficiency. Cell Death & Disease. 11: 303 |
| Pré MFd, Blazevski J, Dewan AE, et al. (2020) B cell tolerance and antibody production to the celiac disease autoantigen transglutaminase 2. Journal of Experimental Medicine. 217 |
| Ooi JD, Jiang JH, Eggenhuizen PJ, et al. (2019) A plasmid-encoded peptide from Staphylococcus aureus induces anti-myeloperoxidase nephritogenic autoimmunity. Nature Communications. 10: 3392 |
| Dendrou CA, Petersen J, Rossjohn J, et al. (2018) HLA variation and disease Nature Reviews Immunology. 18: 325-339 |
| Ooi JD, Petersen J, Tan YH, et al. (2018) Dominant protection from HLA-mediated autoimmune disease is conferred by antigen specific regulatory T cells Pathology. 50: S46-S47 |
| Regev A, Teichmann SA, Lander ES, et al. (2017) Science Forum: The Human Cell Atlas. Elife. 6 |
| Dendrou CA, Fugger L. (2017) Immunomodulation in multiple sclerosis: promises and pitfalls. Current Opinion in Immunology. 49: 37-43 |
| Cortes A, Dendrou CA, Motyer A, et al. (2017) Bayesian analysis of genetic association across tree-structured routine healthcare data in the UK Biobank. Nature Genetics |